Molnupiravir Covid antiviral treatment hastens recovery – trial
But molnupiravir showed no obvious benefit at reducing hospital cases and deaths, a study found. …
Former deputy chief medical officer for England, Prof Sir Jonathan Van-Tam, who is pro-vice-chancellor for the Faculty of Medicine and Health Sciences at the University of Nottingham and study co-author, said: “While molnupiravir was originally found to work well to reduce hospitalisation in patients with Covid, these were unvaccinated patients.
About The Author
